NCT06820762 2025-02-11
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
The Second Affiliated Hospital of Dalian Medical University
Phase 2 Not yet recruiting